<!DOCTYPE html>
<html lang="fa">
 <meta content="text/html;charset=utf-8" http-equiv="content-type"/>
 <head>
  <title>
   Methods to determine hepatic iron content
  </title>
  <link href="d/css/1.css" rel="stylesheet"/>
 </head>
 <body>
  <!-- Start Main Menu Area -->
  <br/>
  <br/>
  <br/>
  <br/>
  <div class="container">
   <div class="row">
   </div>
  </div>
  <section class="teacher-area ptb-10">
   <div class="container">
   </div>
   <section class="course-details-area ptb-60">
    <div class="container">
     <div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
      <h1 style="text-align:center">
       Methods to determine hepatic iron content
      </h1>
      <div class="utdArticleSection utdStyle" id="topicContent">
       <div id="topicTitle">
        Methods to determine hepatic iron content
       </div>
       <div class="authorSectionElem">
        <div class="authorsElementsLeft">
         <dl id="topicContributors">
          <dt>
           <span>
           </span>
           Author:
          </dt>
          <dd>
           <a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">
            Maria Isabel Fiel, MD, FAASLD
           </a>
          </dd>
          <dt>
           <span>
           </span>
           Section Editor:
          </dt>
          <dd>
           <a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">
            Keith D Lindor, MD
           </a>
          </dd>
          <dt>
           <span>
           </span>
           Deputy Editor:
          </dt>
          <dd>
           <a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">
            Kristen M Robson, MD, MBA, FACG
           </a>
          </dd>
         </dl>
        </div>
        <div class="authorsElementsRight">
         <div id="literatureReviewDate">
          <div class="litReviewSingleLine">
           <bdi>
            <span class="emphasis">
             Literature review current through:
            </span>
            Jan 2024.
           </bdi>
          </div>
          <div class="litReviewSingleLine">
           <bdi>
            <span class="emphasis">
             This topic last updated:
            </span>
            Jan 24, 2023.
           </bdi>
          </div>
         </div>
        </div>
       </div>
       <div id="topicWhatsNewContainer">
       </div>
       <div id="topicText">
        <p class="headingAnchor" id="H29216753">
         <span class="h1">
          INTRODUCTION
         </span>
         <span class="headingEndMark">
          —
         </span>
         Hereditary hemochromatosis, hematopoietic stem cell transplantation, myelodysplastic syndrome, chronic liver disease, dialysis, and blood transfusions for sickle cell disease and thalassemia can all cause iron to accumulate in the liver [
         <a href="#rid1">
          1,2
         </a>
         ]. Iron overload is not just limited to the liver, but can also accumulate in other organs, particularly the heart and endocrine organs, resulting in end-organ damage and dysfunction [
         <a href="#rid3">
          3
         </a>
         ]. Hemosiderosis is a commonly used term for iron accumulation in tissues from any cause. (See
         <a class="medical medical_review" href="/z/d/html/7157.html" rel="external">
          "Approach to the patient with suspected iron overload"
         </a>
         .)
        </p>
        <p>
         Oxidative stress resulting in excess oxygen radicals and injury from tissue peroxidation are the main reasons why iron overload causes tissue damage [
         <a href="#rid1">
          1,4
         </a>
         ]. Reducing the degree of iron overload is therefore paramount for most of these diseases to achieve successful treatment. Assessment of total body iron stores can be used to tailor titration of chelation therapy or phlebotomy in an attempt to reduce iron overload and its attendant complications [
         <a href="#rid5">
          5
         </a>
         ]. Phlebotomy has been shown to slow the progression to cirrhosis in hereditary hemochromatosis, and it also reduces the risk of developing hepatocellular carcinoma [
         <a href="#rid6">
          6
         </a>
         ]. Liver fibrosis may be reversible with phlebotomy therapy [
         <a href="#rid7">
          7
         </a>
         ]. The risk of complications related to fibrosis and cirrhosis increases when there is significant iron overload, which is defined as hepatic iron concentration (HIC) greater than three times the upper limit of normal (greater than 90 micromol/g dry weight). Measurement of the HIC in liver tissue remains the reference method for evaluating the magnitude of body iron load. The term HIC was traditionally used for iron content in liver tissue as determined by chemical means. However, the terms HIC or liver iron concentration have been applied for liver iron content using other non-invasive modalities [
         <a href="#rid8">
          8,9
         </a>
         ]. Noninvasive imaging studies such as magnetic resonance imaging (MRI) are also used to evaluate for iron overload. (See
         <a class="local">
          'Magnetic resonance imaging'
         </a>
         below.)
        </p>
        <p>
         Since the discovery of the
         <em>
          HFE
         </em>
         gene mutation (substitution by tyrosine for cysteine at amino acid 282; C282Y) and two other genetic mutations (aspartate for histidine [H63D] and cysteine for serine [S65C]), the diagnosis of hereditary hemochromatosis has become more straightforward [
         <a href="#rid2">
          2
         </a>
         ]. Tests for the
         <em>
          HFE
         </em>
         gene are performed when serum ferritin and transferrin saturation are elevated. However, a small number of individuals with hereditary hemochromatosis may be missed with these genetic tests [
         <a href="#rid3">
          3
         </a>
         ]. Non-HFE forms of hereditary hemochromatosis are related to mutations in genes involved in iron homeostasis other than HFE. These uncommon conditions are caused by defects that affect the hepcidin-ferroportin axis. Additionally, phenotypic penetrance in HFE hereditary hemochromatosis is variable with regard to the degree of iron overload and the risk of liver disease, fibrosis, and cirrhosis [
         <a href="#rid10">
          10
         </a>
         ]. As a result, a positive genetic test does not ensure that iron overload had developed. (See
         <a class="medical medical_review" href="/z/d/html/7167.html" rel="external">
          "Clinical manifestations and diagnosis of hereditary hemochromatosis", section on 'Diagnostic criteria'
         </a>
         .)
        </p>
        <p>
         Determination of the tissue HIC is the most definitive proof of iron overload [
         <a href="#rid11">
          11
         </a>
         ]. It can be used to estimate the total iron burden and the approximate amount of phlebotomy required for a patient with iron overload [
         <a href="#rid1">
          1,12-14
         </a>
         ]. The HIC can also detect mild iron overload, which may be missed with less sensitive modalities [
         <a href="#rid15">
          15
         </a>
         ]. An elevated serum ferritin level alone is often not adequate for estimating total iron burden, particularly if coexisting inflammation is present.
        </p>
        <p>
         This topic will review the tests that can be done to determine hepatic iron content. The approach to a patient with suspected iron overload and the diagnosis of hereditary hemochromatosis are discussed separately. (See
         <a class="medical medical_review" href="/z/d/html/7157.html" rel="external">
          "Approach to the patient with suspected iron overload"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/7167.html" rel="external">
          "Clinical manifestations and diagnosis of hereditary hemochromatosis"
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H73487973">
         <span class="h1">
          DISORDERS ASSOCIATED WITH HEPATIC IRON DEPOSITION
         </span>
         <span class="headingEndMark">
          —
         </span>
         Several forms of liver disease are associated with hepatic iron deposition, including:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Hereditary hemochromatosis
         </strong>
         : The first stage of fibrogenesis in hereditary hemochromatosis is believed to be iron deposition [
         <a href="#rid4">
          4
         </a>
         ]. A ductular reaction characterized by a proliferation of the most terminal branches of the biliary tree precedes the development of fibrosis in patients with hereditary hemochromatosis [
         <a href="#rid16">
          16
         </a>
         ]. Hepatocyte senescence and replicative arrest occur with iron overload and are positively correlated with the hepatic iron concentration (HIC). (See
         <a class="local">
          'Hepatic iron concentration'
         </a>
         below.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Non-HFE hereditary hemochromatosis: Different patterns of iron overload can be seen. Patients with these conditions typically have earlier disease onset as compared with HFE hereditary hemochromatosis. In addition, cardiac involvement and hypogonadism are more prevalent and liver fibrosis and cirrhosis are more commonly seen [
         <a href="#rid17">
          17
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Alcohol-associated liver disease
         </strong>
         : Mild hemosiderosis is found in more than half of patients with alcohol-associated liver disease, even in the absence of cirrhosis [
         <a href="#rid18">
          18,19
         </a>
         ]. However, liver explants from patients with alcohol-related liver disease undergoing liver transplantation show a similar pattern of iron deposition as hereditary hemochromatosis [
         <a href="#rid20">
          20
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Hepatitis C virus (HCV) infection
         </strong>
         : Iron deposition is seen in patients with HCV once cirrhosis develops. In a study of patients with HCV who had paired liver biopsies, histologic progression (defined by increasing fibrosis and portal inflammation) was not associated with a significant increase in HIC. However, a significant increase in HIC was observed once cirrhosis had developed [
         <a href="#rid21">
          21
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Nonalcoholic fatty liver disease (NAFLD)
         </strong>
         : Iron deposition has been seen in NAFLD (
         <a class="graphic graphic_picture graphicRef103741" href="/z/d/graphic/103741.html" rel="external">
          picture 1
         </a>
         ). In two large series, hepatic iron was identified in 35 and 49 percent of patients with NAFLD, respectively [
         <a href="#rid22">
          22,23
         </a>
         ]. In a series of patients with NAFLD and dysmetabolic iron overload syndrome attributed to metabolic abnormalities, the HIC was shown to reach up to 100 micromol/g dry weight [
         <a href="#rid9">
          9,24,25
         </a>
         ]. Hepatic iron has been shown to be related to the development of fibrosis in NAFLD [
         <a href="#rid4">
          4
         </a>
         ], and phlebotomy may improve serum indices in patients with NAFLD [
         <a href="#rid26">
          26
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Cirrhosis
         </strong>
         : Iron overload occurs in cirrhosis regardless of the cause. There is marked heterogeneity in iron distribution from one nodule to another. Because of this, measurements such as the HIC that are taken from liver biopsies may not be reliable or reflective of total iron stores [
         <a href="#rid8">
          8,21
         </a>
         ]. As a result, assessment of hepatic iron in patients with cirrhosis should be interpreted based on histologic findings. Although there is increased iron deposition in noncirrhotic chronic liver disease, the HIC is typically &lt;100 micromol/g dry weight [
         <a href="#rid27">
          27
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Wilson disease
         </strong>
         : Iron overload can be found in association with high copper and zinc levels in Wilson disease [
         <a href="#rid28">
          28
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Porphyria cutanea tarda (PCT)
         </strong>
         : Moderate to marked liver iron overload, whether tested for by serum markers or by HIC, may be seen in patients with PCT. In a cohort of patients with PCT, 19 percent were shown to be homozygous for C282Y and 7 percent heterozygous for C282Y mutation [
         <a href="#rid29">
          29
         </a>
         ]. By comparison, only one percent of control patients had an
         <em>
          HFE
         </em>
         mutation. Phlebotomy is the mainstay of treatment in PCT patients with heavy iron overload [
         <a href="#rid30">
          30,31
         </a>
         ].
        </p>
        <p>
        </p>
        <p>
         The causes of iron overload are discussed elsewhere. (See
         <a class="medical medical_review" href="/z/d/html/7157.html" rel="external">
          "Approach to the patient with suspected iron overload", section on 'Causes of iron overload'
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H29216760">
         <span class="h1">
          HEPATIC IRON CONCENTRATION
         </span>
        </p>
        <p class="headingAnchor" id="H29216767">
         <span class="h2">
          Use of HIC in clinical practice
         </span>
         <span class="headingEndMark">
          —
         </span>
         Determining the hepatic iron concentration (HIC) is rarely needed to make a definitive diagnosis of hereditary hemochromatosis due to the availability of genetic testing [
         <a href="#rid5">
          5,32
         </a>
         ]. However, patients with hereditary hemochromatosis may undergo a liver biopsy to determine the severity of liver disease, in which case the HIC can also be determined to estimate total iron stores. Patients with a serum ferritin &gt;1000 microg/L are at particular risk of advanced fibrosis and may benefit from a staging liver biopsy [
         <a href="#rid5">
          5,33
         </a>
         ]. Studies suggest that the HIC is a reliable indicator of whole liver iron concentration, provided an adequate sample is available (≥1 mg dry weight) [
         <a href="#rid34">
          34
         </a>
         ]. (See
         <a class="medical medical_review" href="/z/d/html/7167.html" rel="external">
          "Clinical manifestations and diagnosis of hereditary hemochromatosis", section on 'Diagnostic criteria'
         </a>
         .)
        </p>
        <p>
         Determining the HIC can also be used for a patient with a suspected genetic iron overload disorder but negative testing for the common genetic mutations: C282Y, H63D, and S65C [
         <a href="#rid10">
          10
         </a>
         ]. However, alternative tests to determine hepatic iron stores (such as magnetic resonance imaging [MRI]) are less invasive. The HIC correlates well with T2-weighted MRI [
         <a href="#rid35">
          35
         </a>
         ], but studies suggest that the sensitivity of MRI is variable [
         <a href="#rid15">
          15
         </a>
         ], so if the suspicion for iron overload is high but an MRI is negative, calculation of the HIC may still be needed. (See
         <a class="local">
          'Magnetic resonance imaging'
         </a>
         below.)
        </p>
        <p class="headingAnchor" id="H29216774">
         <span class="h2">
          Measurement
         </span>
         <span class="headingEndMark">
          —
         </span>
         The HIC is determined using either a colorimetric method or atomic absorption spectrophotometry (AAS) [
         <a href="#rid27">
          27
         </a>
         ]. AAS is the biochemical assay considered to be the reference method [
         <a href="#rid36">
          36
         </a>
         ]. The tests can be performed using fresh liver tissue that has been desiccated or liver tissue removed from a formalin-fixed, paraffin-embedded (FFPE) specimen [
         <a href="#rid27">
          27,34
         </a>
         ]. One study found that the iron content measurements were equivalent using fresh or FFPE tissue [
         <a href="#rid37">
          37
         </a>
         ], while a second study found that FFPE tissue had approximately 23 percent more iron [
         <a href="#rid38">
          38
         </a>
         ]. Dry liver weight taken from FFPE tissue, particularly when the dry weight is ≥0.4 mg, is as accurate as fresh tissue. FFPE to determine the HIC is particularly useful when no fresh tissue is available and the diagnosis of hemochromatosis is only made based on histology [
         <a href="#rid39">
          39
         </a>
         ].
        </p>
        <p>
         The
         <strong>
         </strong>
         HIC is usually reported as micrograms of iron per gram of dry liver weight. The value is then converted to micromoles of iron per gram by dividing by 56, which is the molecular weight of iron [
         <a href="#rid37">
          37
         </a>
         ].
        </p>
        <p>
         As an example:
        </p>
        <div class="formulaContainer">
         <div class="formula">
          <p class="bulletIndent1">
           HIC = 1550 mcg/g dry ÷ 56 = 27.68 micromol/g dry liver weight
          </p>
         </div>
        </div>
        <p>
        </p>
        <p class="headingAnchor" id="H29216788">
         <span class="h2">
          Interpretation
         </span>
         <span class="headingEndMark">
          —
         </span>
         Normal HICs range from 10 to 35 micromol/g dry liver weight [
         <a href="#rid40">
          40
         </a>
         ]. Values &gt;71 micromol/g are considered to be liver iron overload [
         <a href="#rid12">
          12
         </a>
         ]. The HIC is often higher in C282Y homozygotes than in C282Y/H63D compound heterozygotes [
         <a href="#rid41">
          41
         </a>
         ]. In one study, the mean HIC was 13,563 +/- 10,400 mcg/g for C282Y homozygotes versus 7781 +/- 4954 mcg/g for compound heterozygotes [
         <a href="#rid42">
          42
         </a>
         ]. The difference was seen in both patients with and without cirrhosis.
        </p>
        <p>
         The severity of iron overload can be classified as follows [
         <a href="#rid43">
          43
         </a>
         ]:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Mild: HIC &gt;70 to &lt;99 micromol/g dry weight
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Moderate: HIC 99 to 200 micromol/g dry weight
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Severe: HIC ≥200 micromol/g dry weight
        </p>
        <p>
        </p>
        <p>
         In patients with hereditary hemochromatosis, the HIC and serum ferritin level are linearly related to the amount of iron removed with phlebotomy (and as a result, total body iron stores) [
         <a href="#rid12">
          12
         </a>
         ]. Changes in the HIC and ferritin levels can help estimate phlebotomy needs over time, though neither can accurately predict the phlebotomy requirements for a given patient at the time of initial diagnosis [
         <a href="#rid12">
          12
         </a>
         ]. HIC is also predictive of total body iron stores in patients with thalassemia major [
         <a href="#rid34">
          34,44
         </a>
         ].
        </p>
        <p>
         In patients with hereditary hemochromatosis, the HIC is higher in patients with cirrhosis than in patients without cirrhosis [
         <a href="#rid45">
          45
         </a>
         ]. In the absence of other chronic liver disease, cirrhosis typically develops once the HIC is over 250 to 300 micromol/g [
         <a href="#rid46">
          46
         </a>
         ]. In one study, the HIC was 85 percent sensitive and 84 percent specific for predicting cirrhosis when a cutoff value of ≥283 micromol/g was used [
         <a href="#rid45">
          45
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H29216809">
         <span class="h1">
          HEPATIC IRON INDEX
         </span>
        </p>
        <p>
         The hepatic iron index (HII) is calculated from the hepatic iron concentration by dividing the quantitative iron in micromoles per gram of dry liver weight by the patient's age. Prior to the discovery of the
         <em>
          HFE
         </em>
         gene mutation, an HII of &gt;1.9 was considered to be diagnostic for hereditary hemochromatosis [
         <a href="#rid6">
          6
         </a>
         ]. However, the HII has been shown to be elevated even in those without the
         <em>
          HFE
         </em>
         genetic mutation [
         <a href="#rid47">
          47
         </a>
         ].
        </p>
        <p>
         A simple semiquantitative grading system for the amount of iron deposition (0 to 3) in liver biopsies based on iron staining has shown good correlation with the HII in patients with hereditary hemochromatosis [
         <a href="#rid48">
          48
         </a>
         ]. In one study, a score of 1+ corresponded to an HII ≤1.9, a score of 2+ with an HII score of &gt;2, and a score of 3+ correlated with an HII ≥4.4 (up to 8.3) [
         <a href="#rid48">
          48
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H29216822">
         <span class="h1">
          OTHER METHODS TO DETERMINE IRON OVERLOAD
         </span>
         <span class="headingEndMark">
          —
         </span>
         Other methods to evaluate iron overload include serum iron indices, magnetic resonance imaging (MRI), and histologic evaluation of liver biopsy specimens.
         <strong>
         </strong>
        </p>
        <p class="headingAnchor" id="H29216829">
         <span class="h2">
          Iron indices
         </span>
         <span class="headingEndMark">
          —
         </span>
         Serum ferritin and transferrin saturation levels are the values most commonly used to determine iron overload [
         <a href="#rid5">
          5
         </a>
         ]. However, increased levels of serum ferritin can be caused by a variety of inflammatory states, metabolic disorders, neoplastic processes, diabetes, nonalcoholic fatty liver disease, and alcohol liver injury, and do not necessarily quantitatively reflect body iron content [
         <a href="#rid2">
          2
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H29216836">
         <span class="h2">
          Magnetic resonance imaging
         </span>
         <span class="headingEndMark">
          —
         </span>
         Noninvasive imaging studies such as magnetic resonance imaging (MRI) using T2 and R2 (FerriScan) measurements have become increasingly accurate for determining hepatic iron deposition and quantifying its severity (
         <a class="graphic graphic_diagnosticimage graphicRef56593" href="/z/d/graphic/56593.html" rel="external">
          image 1
         </a>
         ) [
         <a href="#rid49">
          49-53
         </a>
         ]. Liver iron concentration (LIC, estimated by MRI) that is &gt;3 to 7 mg Fe/g dry weight (equivalent to approximately 53 to 125 micromol/g dry weight) indicates hepatic iron overload. The indications for and diagnostic accuracy of MRI in the evaluation of patients with suspected iron overload is discussed separately [
         <a href="#rid15">
          15
         </a>
         ]. (See
         <a class="medical medical_review" href="/z/d/html/7157.html" rel="external">
          "Approach to the patient with suspected iron overload", section on 'Noninvasive imaging (MRI)'
         </a>
         .)
        </p>
        <p>
         The noninvasive reference standard for measurement of liver iron concentration is the biomagnetic liver susceptometry (BLS) using a superconducting quantum interference device (SQUID), which measures magnetic susceptibility, a quantitative property of tissue. When iron is present, the magnetic susceptibility of the liver is altered. Despite the advantages of the SQUID biomagnetometer, this system is available in only a few centers worldwide [
         <a href="#rid54">
          54
         </a>
         ]. MRI-based quantitative susceptibility mapping (QSM) and confounder-corrected R2 mapping of the liver to estimate liver iron concentration has been shown to correlate with SQUID-BLS [
         <a href="#rid54">
          54
         </a>
         ]. Because of correlation with SQUID, the MRI-based QSM shows promise as a more accessible method to determine liver iron concentration.
        </p>
        <p class="headingAnchor" id="H29216843">
         <span class="h2">
          Liver biopsy
         </span>
         <span class="headingEndMark">
          —
         </span>
         Liver biopsies remain the reference standard for measuring HIC [
         <a href="#rid8">
          8
         </a>
         ]. In patients with hereditary hemochromatosis (HH) biopsies are typically performed to stage the degree of fibrosis, assess hepatic damage, and sometimes to quantify the HIC [
         <a href="#rid11">
          11
         </a>
         ]. In addition, liver biopsy can identify both the pattern and grade of liver iron deposition [
         <a href="#rid48">
          48,55
         </a>
         ]. Liver biopsy can also identify other concurrent pathology, such as fatty liver disease and other metabolic disorders [
         <a href="#rid27">
          27
         </a>
         ]. (See
         <a class="medical medical_review" href="/z/d/html/7167.html" rel="external">
          "Clinical manifestations and diagnosis of hereditary hemochromatosis", section on 'Liver biopsy for selected patients'
         </a>
         .)
        </p>
        <p>
         Liver biopsy specimens may be processed routinely, embedded in paraffin, and stained with hematoxylin-eosin, Masson trichrome, and a Perls' Prussian blue stain. The Prussian blue stain will highlight the degree and pattern of distribution of iron deposition (
         <a class="graphic graphic_picture graphicRef103742" href="/z/d/graphic/103742.html" rel="external">
          picture 2
         </a>
         ) [
         <a href="#rid27">
          27
         </a>
         ].
        </p>
        <p>
         Early in the course of hereditary hemochromatosis, there is a decreasing gradient of parenchymal iron distribution from periportal to centrilobular areas (seen in &gt;93 percent of patients) (
         <a class="graphic graphic_picture graphicRef105340" href="/z/d/graphic/105340.html" rel="external">
          picture 3
         </a>
         ) [
         <a href="#rid56">
          56
         </a>
         ]. The pattern is not specific for the C282Y
         <em>
          HFE
         </em>
         gene mutation [
         <a href="#rid55">
          55
         </a>
         ].
        </p>
        <p>
         Several scoring systems for hepatic iron deposition have been developed. Although not validated, the most commonly used are the Scheuer method and its modified version because of their simplicity [
         <a href="#rid57">
          57
         </a>
         ]. The score is based on the percentage of hepatocytes with iron, and ranges from 0 to 4. Other scoring systems that have been developed are the Deugnier and Turlin, Rowe, Sindram and Marx, Conn, and Brissot systems [
         <a href="#rid27">
          27
         </a>
         ]. Deugnier's histological scoring system correlates with measurement of the HIC [
         <a href="#rid36">
          36
         </a>
         ]. There is also a modification of the histological scoring system for iron overload by Sindram and Marx that includes the size of iron granules to reach a final score. When this system was used in one study, there was a strong correlation between histologic score and HIC [
         <a href="#rid58">
          58
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H29216850">
         <span class="h1">
          SUMMARY
         </span>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         The role for hepatic iron concentration (HIC) and hepatic iron index (HII) determination has greatly diminished since genetic testing for hereditary hemochromatosis has become widely available. Determining the HIC is rarely needed to make a definitive diagnosis of hereditary hemochromatosis. However, patients with hereditary hemochromatosis may undergo liver biopsy to determine the severity of liver disease, in which case the HIC can also be determined to estimate total iron stores. The HIC appears to be a reliable indicator of whole liver iron concentration, provided an adequate sample is available (≥1 mg dry weight). (See
         <a class="local">
          'Use of HIC in clinical practice'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Determining the HIC can be used for a patient with a suspected genetic iron overload disorder but with negative testing for the common genetic mutations: C282Y, H63D, and S65C. However, alternative tests to determine hepatic iron stores (such as magnetic resonance imaging) are less invasive. (See
         <a class="local">
          'Use of HIC in clinical practice'
         </a>
         above and
         <a class="local">
          'Magnetic resonance imaging'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         The HIC is usually reported as micrograms of iron per gram of dry liver weight. The value is then converted to micromoles of iron per gram by dividing by 56, which is the molecular weight of iron. (See
         <a class="local">
          'Measurement'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         The severity of iron overload can be classified as follows:
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Mild: HIC &gt;70 to &lt;99 micromol/g dry weight
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Moderate: HIC 99 to 200 micromol/g dry weight
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Severe: HIC ≥200 micromol/g dry weight
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         The HII is calculated from the HIC by dividing the quantitative iron in micromoles per gram of dry weight by the patient's age. Prior to the discovery of the
         <em>
          HFE
         </em>
         gene mutation, an HII of &gt;1.9 was considered to be diagnostic for hereditary hemochromatosis. However, the HII can be elevated even in patients without the
         <em>
          HFE
         </em>
         genetic mutation. (See
         <a class="local">
          'Hepatic iron index'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Other methods to evaluate iron overload include serum iron indices, magnetic resonance imaging, and histologic evaluation of liver biopsy specimens. (See
         <a class="local">
          'Other methods to determine iron overload'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H29216952">
         <span class="h1">
          ACKNOWLEDGMENT
         </span>
         <span class="headingEndMark">
          —
         </span>
         The UpToDate editorial staff acknowledges Bruce Bacon, MD, who contributed to an earlier version of this topic review.
        </p>
       </div>
       <div class="headingAnchor" id="references">
        <ol id="reference">
         <li>
          <a class="nounderline abstract_t">
           Brissot P, Troadec MB, Bardou-Jacquet E, et al. Current approach to hemochromatosis. Blood Rev 2008; 22:195.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Pietrangelo A. Hereditary hemochromatosis: pathogenesis, diagnosis, and treatment. Gastroenterology 2010; 139:393.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Bardou-Jacquet E, Ben Ali Z, Beaumont-Epinette MP, et al. Non-HFE hemochromatosis: pathophysiological and diagnostic aspects. Clin Res Hepatol Gastroenterol 2014; 38:143.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           O'Brien J, Powell LW. Non-alcoholic fatty liver disease: is iron relevant? Hepatol Int 2012; 6:332.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Bacon BR, Adams PC, Kowdley KV, et al. Diagnosis and management of hemochromatosis: 2011 practice guideline by the American Association for the Study of Liver Diseases. Hepatology 2011; 54:328.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Kowdley KV, Trainer TD, Saltzman JR, et al. Utility of hepatic iron index in American patients with hereditary hemochromatosis: a multicenter study. Gastroenterology 1997; 113:1270.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Nadakkavukaran IM, Gan EK, Olynyk JK. Screening for hereditary haemochromatosis. Pathology 2012; 44:148.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Brittenham GM. Reference method for measurement of the hepatic iron concentration. Am J Hematol 2015; 90:85.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Britton L, Bridle K, Reiling J, et al. Hepatic iron concentration correlates with insulin sensitivity in nonalcoholic fatty liver disease. Hepatol Commun 2018; 2:644.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Bacon BR, Britton RS. Clinical penetrance of hereditary hemochromatosis. N Engl J Med 2008; 358:291.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Bacon BR. Measurement of hepatic iron concentration. Clin Gastroenterol Hepatol 2015; 13:64.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Olynyk JK, Luxon BA, Britton RS, Bacon BR. Hepatic iron concentration in hereditary hemochromatosis does not saturate or accurately predict phlebotomy requirements. Am J Gastroenterol 1998; 93:346.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Salgia RJ, Brown K. Diagnosis and management of hereditary hemochromatosis. Clin Liver Dis 2015; 19:187.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Ali S, Pimentel JD, Munoz J, et al. Iron overload in allogeneic hematopoietic stem cell transplant recipients. Arch Pathol Lab Med 2012; 136:532.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Sarigianni M, Liakos A, Vlachaki E, et al. Accuracy of magnetic resonance imaging in diagnosis of liver iron overload: a systematic review and meta-analysis. Clin Gastroenterol Hepatol 2015; 13:55.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Wood MJ, Gadd VL, Powell LW, et al. Ductular reaction in hereditary hemochromatosis: the link between hepatocyte senescence and fibrosis progression. Hepatology 2014; 59:848.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Sandhu K, Flintoff K, Chatfield MD, et al. Phenotypic analysis of hemochromatosis subtypes reveals variations in severity of iron overload and clinical disease. Blood 2018; 132:101.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Jakobovits AW, Morgan MY, Sherlock S. Hepatic siderosis in alcoholics. Dig Dis Sci 1979; 24:305.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Harrison-Findik DD. Role of alcohol in the regulation of iron metabolism. World J Gastroenterol 2007; 13:4925.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Fierro-Fine A, Guerin L, Hicsasmaz H, Brown KE. Clinical Factors Associated with Hepatocellular Iron Deposition in End-stage Liver Disease. J Clin Transl Hepatol 2020; 8:231.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Larson AM, Taylor SL, Bauermeister D, et al. Pilot study of the relationship between histologic progression and hepatic iron concentration in chronic hepatitis C. J Clin Gastroenterol 2003; 37:406.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Nelson JE, Wilson L, Brunt EM, et al. Relationship between the pattern of hepatic iron deposition and histological severity in nonalcoholic fatty liver disease. Hepatology 2011; 53:448.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Valenti L, Fracanzani AL, Bugianesi E, et al. HFE genotype, parenchymal iron accumulation, and liver fibrosis in patients with nonalcoholic fatty liver disease. Gastroenterology 2010; 138:905.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Turlin B, Mendler MH, Moirand R, et al. Histologic features of the liver in insulin resistance-associated iron overload. A study of 139 patients. Am J Clin Pathol 2001; 116:263.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Britton LJ, Subramaniam VN, Crawford DH. Iron and non-alcoholic fatty liver disease. World J Gastroenterol 2016; 22:8112.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Aigner E, Theurl I, Theurl M, et al. Pathways underlying iron accumulation in human nonalcoholic fatty liver disease. Am J Clin Nutr 2008; 87:1374.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Deugnier Y, Turlin B. Pathology of hepatic iron overload. Semin Liver Dis 2011; 31:260.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Boaru SG, Merle U, Uerlings R, et al. Laser ablation inductively coupled plasma mass spectrometry imaging of metals in experimental and clinical Wilson's disease. J Cell Mol Med 2015; 19:806.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Bulaj ZJ, Phillips JD, Ajioka RS, et al. Hemochromatosis genes and other factors contributing to the pathogenesis of porphyria cutanea tarda. Blood 2000; 95:1565.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Aarsand AK, Boman H, Sandberg S. Familial and sporadic porphyria cutanea tarda: characterization and diagnostic strategies. Clin Chem 2009; 55:795.
          </a>
         </li>
         <li class="breakAll">
          Liu LU, Phillips J, Bonkovsky H. Porphyria Cutanea Tarda, Type II. In: GeneReviews, Pagon RA, Adam MP, Ardinger HH, Wallace SE, Amemiya A, Bean LJH, Bird TD, Dolan CR, Fong CT, Smith R (Eds), University of Washington, Seattle 2013.
         </li>
         <li>
          <a class="nounderline abstract_t">
           Olynyk JK, Trinder D, Ramm GA, et al. Hereditary hemochromatosis in the post-HFE era. Hepatology 2008; 48:991.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           European Association For The Study Of The Liver. EASL clinical practice guidelines for HFE hemochromatosis. J Hepatol 2010; 53:3.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Urru SA, Tandurella I, Capasso M, et al. Reproducibility of liver iron concentration measured on a biopsy sample: a validation study in vivo. Am J Hematol 2015; 90:87.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Gandon Y, Olivié D, Guyader D, et al. Non-invasive assessment of hepatic iron stores by MRI. Lancet 2004; 363:357.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Deugnier Y, Margules S, Brissot P, et al. Comparative study between biochemical and histological methods and image analysis in liver iron overload. J Clin Pathol 1982; 35:45.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Olynyk JK, O'Neill R, Britton RS, Bacon BR. Determination of hepatic iron concentration in fresh and paraffin-embedded tissue: diagnostic implications. Gastroenterology 1994; 106:674.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Butensky E, Fischer R, Hudes M, et al. Variability in hepatic iron concentration in percutaneous needle biopsy specimens from patients with transfusional hemosiderosis. Am J Clin Pathol 2005; 123:146.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Beilby JP, Prins AW, Swanson NR. Determination of hepatic iron concentration in fresh and paraffin-embedded tissue. Clin Chem 1999; 45:573.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Brissot P, Bourel M, Herry D, et al. Assessment of liver iron content in 271 patients: a reevaluation of direct and indirect methods. Gastroenterology 1981; 80:557.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Bacon BR, Olynyk JK, Brunt EM, et al. HFE genotype in patients with hemochromatosis and other liver diseases. Ann Intern Med 1999; 130:953.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Cheng R, Barton JC, Morrison ED, et al. Differences in hepatic phenotype between hemochromatosis patients with HFE C282Y homozygosity and other HFE genotypes. J Clin Gastroenterol 2009; 43:569.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Adams P, Brissot P, Powell LW. EASL International Consensus Conference on Haemochromatosis. J Hepatol 2000; 33:485.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Angelucci E, Brittenham GM, McLaren CE, et al. Hepatic iron concentration and total body iron stores in thalassemia major. N Engl J Med 2000; 343:327.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Adams PC. Is there a threshold of hepatic iron concentration that leads to cirrhosis in C282Y hemochromatosis? Am J Gastroenterol 2001; 96:567.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Powell LW, Dixon JL, Ramm GA, et al. Screening for hemochromatosis in asymptomatic subjects with or without a family history. Arch Intern Med 2006; 166:294.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Cotler SJ, Bronner MP, Press RD, et al. End-stage liver disease without hemochromatosis associated with elevated hepatic iron index. J Hepatol 1998; 29:257.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Nash S, Marconi S, Sikorska K, et al. Role of liver biopsy in the diagnosis of hepatic iron overload in the era of genetic testing. Am J Clin Pathol 2002; 118:73.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Banerjee R, Pavlides M, Tunnicliffe EM, et al. Multiparametric magnetic resonance for the non-invasive diagnosis of liver disease. J Hepatol 2014; 60:69.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Wood JC. Estimating tissue iron burden: current status and future prospects. Br J Haematol 2015; 170:15.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           St Pierre TG, El-Beshlawy A, Elalfy M, et al. Multicenter validation of spin-density projection-assisted R2-MRI for the noninvasive measurement of liver iron concentration. Magn Reson Med 2014; 71:2215.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Paisant A, d'Assignies G, Bannier E, et al. MRI for the measurement of liver iron content, and for the diagnosis and follow-up of iron overload disorders. Presse Med 2017; 46:e279.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Hernando D, Zhao R, Yuan Q, et al. Multicenter Reproducibility of Liver Iron Quantification with 1.5-T and 3.0-T MRI. Radiology 2023; 306:e213256.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Sharma SD, Fischer R, Schoennagel BP, et al. MRI-based quantitative susceptibility mapping (QSM) and R2* mapping of liver iron overload: Comparison with SQUID-based biomagnetic liver susceptometry. Magn Reson Med 2017; 78:264.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Brunt EM, Olynyk JK, Britton RS, et al. Histological evaluation of iron in liver biopsies: relationship to HFE mutations. Am J Gastroenterol 2000; 95:1788.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Deugnier YM, Loréal O, Turlin B, et al. Liver pathology in genetic hemochromatosis: a review of 135 homozygous cases and their bioclinical correlations. Gastroenterology 1992; 102:2050.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           SCHEUER PJ, WILLIAMS R, MUIR AR. Hepatic pathology in relatives of patients with haemochromatosis. J Pathol Bacteriol 1962; 84:53.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Tavassoli H, Mahjoub F, Jahanzad E, et al. Introducing a new histologic scoring system for iron deposition in liver of thalassemic patients, compared with atomic absorption spectrometry. Exp Toxicol Pathol 2015; 67:365.
          </a>
         </li>
        </ol>
       </div>
       <div id="topicVersionRevision">
        Topic 3614 Version 25.0
       </div>
      </div>
      <div class="row">
       <div class="col-12">
        <h4 style="text-align: center;padding: 20px;color: cadetblue;">
         References
        </h4>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/18430498" id="rid0" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          1 : Current approach to hemochromatosis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/20542038" id="rid1" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          2 : Hereditary hemochromatosis: pathogenesis, diagnosis, and treatment.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/24321703" id="rid2" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          3 : Non-HFE hemochromatosis: pathophysiological and diagnostic aspects.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/22020821" id="rid3" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          4 : Non-alcoholic fatty liver disease: is iron relevant?
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/21452290" id="rid4" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          5 : Diagnosis and management of hemochromatosis: 2011 practice guideline by the American Association for the Study of Liver Diseases.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/9322522" id="rid5" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          6 : Utility of hepatic iron index in American patients with hereditary hemochromatosis: a multicenter study.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/22198253" id="rid6" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          7 : Screening for hereditary haemochromatosis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/25488360" id="rid7" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          8 : Reference method for measurement of the hepatic iron concentration.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/29881816" id="rid8" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          9 : Hepatic iron concentration correlates with insulin sensitivity in nonalcoholic fatty liver disease.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/18199868" id="rid9" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          10 : Clinical penetrance of hereditary hemochromatosis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/25220938" id="rid10" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          11 : Measurement of hepatic iron concentration.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/9517637" id="rid11" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          12 : Hepatic iron concentration in hereditary hemochromatosis does not saturate or accurately predict phlebotomy requirements.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/25454304" id="rid12" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          13 : Diagnosis and management of hereditary hemochromatosis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/22540302" id="rid13" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          14 : Iron overload in allogeneic hematopoietic stem cell transplant recipients.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/24993364" id="rid14" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          15 : Accuracy of magnetic resonance imaging in diagnosis of liver iron overload: a systematic review and meta-analysis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/24037895" id="rid15" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          16 : Ductular reaction in hereditary hemochromatosis: the link between hepatocyte senescence and fibrosis progression.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/29743178" id="rid16" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          17 : Phenotypic analysis of hemochromatosis subtypes reveals variations in severity of iron overload and clinical disease.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/465138" id="rid17" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          18 : Hepatic siderosis in alcoholics.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/17854133" id="rid18" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          19 : Role of alcohol in the regulation of iron metabolism.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/33083244" id="rid19" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          20 : Clinical Factors Associated with Hepatocellular Iron Deposition in End-stage Liver Disease.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/14564190" id="rid20" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          21 : Pilot study of the relationship between histologic progression and hepatic iron concentration in chronic hepatitis C.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/21274866" id="rid21" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          22 : Relationship between the pattern of hepatic iron deposition and histological severity in nonalcoholic fatty liver disease.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/19931264" id="rid22" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          23 : HFE genotype, parenchymal iron accumulation, and liver fibrosis in patients with nonalcoholic fatty liver disease.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/11488074" id="rid23" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          24 : Histologic features of the liver in insulin resistance-associated iron overload. A study of 139 patients.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/27688653" id="rid24" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          25 : Iron and non-alcoholic fatty liver disease.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/18469261" id="rid25" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          26 : Pathways underlying iron accumulation in human nonalcoholic fatty liver disease.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/21901656" id="rid26" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          27 : Pathology of hepatic iron overload.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/25704483" id="rid27" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          28 : Laser ablation inductively coupled plasma mass spectrometry imaging of metals in experimental and clinical Wilson's disease.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/10688809" id="rid28" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          29 : Hemochromatosis genes and other factors contributing to the pathogenesis of porphyria cutanea tarda.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/19233912" id="rid29" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          30 : Familial and sporadic porphyria cutanea tarda: characterization and diagnostic strategies.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/19233912" id="rid30" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          31 : Familial and sporadic porphyria cutanea tarda: characterization and diagnostic strategies.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/18752323" id="rid31" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          32 : Hereditary hemochromatosis in the post-HFE era.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/20471131" id="rid32" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          33 : EASL clinical practice guidelines for HFE hemochromatosis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/25345839" id="rid33" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          34 : Reproducibility of liver iron concentration measured on a biopsy sample: a validation study in vivo.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/15070565" id="rid34" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          35 : Non-invasive assessment of hepatic iron stores by MRI.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/7037861" id="rid35" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          36 : Comparative study between biochemical and histological methods and image analysis in liver iron overload.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/8119539" id="rid36" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          37 : Determination of hepatic iron concentration in fresh and paraffin-embedded tissue: diagnostic implications.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/15762291" id="rid37" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          38 : Variability in hepatic iron concentration in percutaneous needle biopsy specimens from patients with transfusional hemosiderosis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/10102921" id="rid38" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          39 : Determination of hepatic iron concentration in fresh and paraffin-embedded tissue.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/7450446" id="rid39" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          40 : Assessment of liver iron content in 271 patients: a reevaluation of direct and indirect methods.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/10383365" id="rid40" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          41 : HFE genotype in patients with hemochromatosis and other liver diseases.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/19359997" id="rid41" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          42 : Differences in hepatic phenotype between hemochromatosis patients with HFE C282Y homozygosity and other HFE genotypes.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/11020008" id="rid42" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          43 : EASL International Consensus Conference on Haemochromatosis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/10922422" id="rid43" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          44 : Hepatic iron concentration and total body iron stores in thalassemia major.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/11232708" id="rid44" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          45 : Is there a threshold of hepatic iron concentration that leads to cirrhosis in C282Y hemochromatosis?
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/16476869" id="rid45" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          46 : Screening for hemochromatosis in asymptomatic subjects with or without a family history.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/9722207" id="rid46" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          47 : End-stage liver disease without hemochromatosis associated with elevated hepatic iron index.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/12109859" id="rid47" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          48 : Role of liver biopsy in the diagnosis of hepatic iron overload in the era of genetic testing.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/24036007" id="rid48" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          49 : Multiparametric magnetic resonance for the non-invasive diagnosis of liver disease.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/25765344" id="rid49" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          50 : Estimating tissue iron burden: current status and future prospects.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/23821350" id="rid50" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          51 : Multicenter validation of spin-density projection-assisted R2-MRI for the noninvasive measurement of liver iron concentration.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/29133084" id="rid51" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          52 : MRI for the measurement of liver iron content, and for the diagnosis and follow-up of iron overload disorders.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/36194113" id="rid52" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          53 : Multicenter Reproducibility of Liver Iron Quantification with 1.5-T and 3.0-T MRI.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/27509836" id="rid53" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          54 : MRI-based quantitative susceptibility mapping (QSM) and R2* mapping of liver iron overload: Comparison with SQUID-based biomagnetic liver susceptometry.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/10925986" id="rid54" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          55 : Histological evaluation of iron in liver biopsies: relationship to HFE mutations.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/1587423" id="rid55" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          56 : Liver pathology in genetic hemochromatosis: a review of 135 homozygous cases and their bioclinical correlations.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/14498313" id="rid56" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          57 : Hepatic pathology in relatives of patients with haemochromatosis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/25911308" id="rid57" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          58 : Introducing a new histologic scoring system for iron deposition in liver of thalassemic patients, compared with atomic absorption spectrometry.
         </p>
        </a>
       </div>
      </div>
     </div>
    </div>
   </section>
  </section>
  <!-- End Main Menu Area -->
  <!-- Start Search Popup Area -->
  <!-- End Footer Area -->
  <!-- Back to top -->
  <a class="scrolltop" href="#top">
   <i class="icofont-hand-drawn-up">
   </i>
  </a>
  <!-- End Back to top -->
  <!-- jQuery Min JS -->
  <!-- Prpper JS -->
  <!-- Bootstrap Min JS -->
  <!-- Classy Nav Min Js -->
  <!-- Owl Carousel Min Js -->
  <!-- Magnific Popup JS -->
  <!-- CounterUp JS -->
  <!-- Waypoints JS -->
  <!-- Form Validator Min JS -->
  <!-- Contact Form Min JS -->
  <!-- Main JS -->
  <!-- Global site tag (gtag.js) - Google Analytics -->
 </body>
</html>
